A long-term trade is looking for Vertex Pharmaceuticals to explode higher by next spring.
More than 3,200 April 82.50 calls were purchased yesterday, led by a print of 3,000 that went for $11.10. This is clearly fresh buying, as open interest in the strike was a mere 65 contracts before the trades appeared.
These long calls are far out of the money and are betting that VRTX will rally above $93.60, a level not seen since November 2000 by mid-April 2014. They could be sold earlier at a profit if premiums rise with a rally before then, but the contracts could expire worthless if shares remain below $82.50. (See our Education section)
VRTX gained 2.69 percent yesterday to close at $78.40. Shares gapped up from about $53 to above $85 in April on positive clinical-trial results for its experiment treatment of cystic fibrosis, and they have been range-bound between $75 and $90 since then.
Overall option volume in VRTX totaled 4,700 yesterday, 34 times its daily average for the last month. Only 139 of those contracts were puts, a further indication of yesterday's bullish sentiment.
More From optionMONSTER
- Trader bets on more gains in Darling
- Videocast: VIX call buying subsides
- Midday index, ETF option volumes
- Investment & Company Information
- Vertex Pharmaceuticals